ORALLY-ACTIVE BETA-LACTAM INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE .3. STEREOSPECIFIC SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS FOR 3,3-DIALKYLAZETIDIN-2-ONES
Pe. Finke et al., ORALLY-ACTIVE BETA-LACTAM INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE .3. STEREOSPECIFIC SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS FOR 3,3-DIALKYLAZETIDIN-2-ONES, Journal of medicinal chemistry, 38(13), 1995, pp. 2449-2462
The stereospecific synthesis of several -1-[[(1-phenylalkyl)amino]carb
onyl]azetidin-2-ones 3 is described in which the C-3 alkyl groups were
varied from methyl to butyl as well as allyl, benzyl and methoxymethy
l. The structure-activity relations for these compounds are discussed
in terms of the hydrolytic stability of the beta-lactam ring, their in
vitro inhibitory Potency for human leukocyte elastase (HLE), and thei
r in vivo oral efficacy in an HLE-mediated hamster lung hemorrhage ass
ay. Further alkyl substitution on the benzylic urea moiety, especially
in the R configuration, afforded enhanced HLE inhibition and in vivo
efficacy. The stereochemical assignments for (3R,4S)-4-[(4-carboxyphen
yl)oxy]-3-ethyl-3 [((R)-1-phenylpropyl)amino]carbonyl]azetidin-2-one (
42a) (k(obs)/[I] = 91 000 M(-1) s(-1)) were confirmed with an X-ray st
ructure determination, which was also utilized to develop an HLE inhib
ition model.